(Contributed) September 19, 2018 — Santa Cruz, CA SomaGenics, a biotechnology company focused on developing lowest bias sequencing and highest..
(Contributed) April 24, 2018 — Santa Cruz, CA SomaGenics’ NIH-funded project to accelerate wound healing in diabetic patients aims at restoring the..
(Contributed) December 21, 2017 — Santa Cruz, CA SomaGenics, an RNA-focused biotechnology company, expands its IP protection with three newly issued..
(Contributed) October 10, 2017 — Santa Cruz, CA SomaGenics announced the receipt of a Phase I SBIR grant from NIH to develop RealSeq®-SC (Single Cell),..
(Contributed) May 25, 2017 — Santa Cruz, CA SomaGenics announced the receipt of a $270K Phase I SBIR grant from the National Human Genome Research..
(Contributed) April 13, 2017 — Santa Cruz, CA Welcome to the future of wound care SomaGenics presented recent progress in its wound healing therapeutic..
(Contributed) October 6, 2016 — Santa Cruz, CA SomaGenics has been awarded a $1.7M two-year NIH SBIR Phase II grant to further develop its RealSeq®–AC..
(Contributed) July 28, 2016 — Santa Cruz, CA SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for..
By Jan Janes Special to Santa Cruz Tech Beat (Photo above: Researchers and CEOs after their presentations (l-r) Ravi Jain, Managing Director, UC Santa Cruz..
By Sara Isenberg Founder, Publisher, Editor-in-Chief of Santa Cruz Tech Beat April 30, 2015 — Santa Cruz, CA Somagenics awarded two-year NIH grant..